Results 211 to 220 of about 5,354,149 (260)

Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients. [PDF]

open access: yesSci Rep, 2019
Careta O   +7 more
europepmc   +1 more source

In situ imaging reveals properties of purinergic signalling in trigeminal sensory ganglia in vitro. [PDF]

open access: yesPurinergic Signal, 2017
Nowodworska A   +3 more
europepmc   +1 more source

Editorial: Purinergic signaling in metabolic diseases and inflammation pharmacology

open access: yesFrontiers in Pharmacology
Alejandro Sánchez-Melgar   +2 more
doaj   +1 more source

In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend. [PDF]

open access: yesPurinergic Signal
Falzoni S   +8 more
europepmc   +1 more source

Latest advances on the role of P2X Receptors in colorectal inflammation and cancer. [PDF]

open access: yesPurinergic Signal
Ruo L   +4 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Interplay between purinergic signalling and extracellular vesicles in health and disease.

Biochemical Pharmacology, 2022
Purinergic signalling is a receptor-mediated process characterized by the binding of extracellular nucleotides and nucleosides to purinergic receptors, which results in the activation intracellular signalling pathways, and, ultimately, leads to changes ...
Valentina Carotti   +3 more
semanticscholar   +3 more sources

Purinergic signalling and brain development.

Seminars in Cell & Developmental Biology, 2019
ATP and adenosine are released from cells as a function of their metabolic activity, being important cell-to-cell communication signals. Both purines are also released from neurons in an activity-dependent manner, with several established roles to fine ...
R. Rodrigues, Joana M Marques, R. Cunha
semanticscholar   +3 more sources

Extracellular ATP and P2 purinergic signalling in the tumour microenvironment

Nature Reviews Cancer, 2018
F. Di Virgilio   +4 more
semanticscholar   +3 more sources

Purinergic signalling in graft-versus-host disease.

Current opinion in pharmacology (Print), 2023
Allogeneic hematopoietic stem cell transplantation is used to treat blood cancers, but often results in lethal graft-versus-host disease (GVHD). GVHD is an inflammatory disorder mediated by donor leukocytes that damage host tissues. Purinergic signalling
R. Sluyter   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy